Aurinia Pharmaceuticals (NasdaqGM:AUPH) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsGreg Keenan - Chief Medical OfficerJoe Miller - CFOPeter Greenleaf - President and CEOSahil Dhingra - Senior Equity Research AssociateWill Sawicki - AssociateConference Call ParticipantsArthur He - AnalystDavid Martin - AnalystFarzin Haque - Senior Vice President and Biotechnology Equity Research AnalystOlivia Brayer - Senior Equity AnalystOperatorGood morning. Welcome to the Aurinia Pharmaceutica ...

Delcath Systems (NasdaqCM:DCTH) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsBill Maughan - Managing DirectorCharles Wallace - Managing DirectorDavid Hoffman - General Counsel, Corporate Secretary and CCOGerard Michel - CEOJohn Newman - Managing DirectorSandra Pennell - CFOSudan Loganathan - Managing DirectorConference Call ParticipantsChase Knickerbocker - Senior Research AnalystMarie Thibault - Managing Director and Medical Technology and Digital Health AnalystYale Jen - Senior ...

argenx (NasdaqGS:ARGX) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsAkash Tewari - Global Head of Biopharmaceutical ResearchAlex Thompson - Managing DirectorBeth DelGiacco - VP of Corporate AffairsDanielle Brill - Managing DirectorDouglas Tsao - Managing DirectorJames Gordon - Director and Head of European PharmaJustin Smith - DirectorKaren Massey - COOKarl Gubitz - CFOLuc Truyen - Chief Medical OfficerMatt Phipps - Partner and Group Head of BiotechnologyRajan Sharma - Executive D ...

Wave Life Sciences (NasdaqGM:WVE) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsCatherine Novack - Director of Healthcare Equity ResearchCha Cha Yang - Senior Associate, Biotech Equity ResearchCheng Li - Director of Biotech Equity ResearchChristopher Wright - CMOErik Ingelsson - Chief Scientific OfficerJoon Lee - Managing DirectorKate Rausch - VP of Corporate Affairs and Investor RelationsKyle Moran - CFOLillian Yuen-Ho - Financial PlannerPaul B. Bolno - President and CEOPaul Bolno ...

Heron Therapeutics (NasdaqCM:HRTX) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsCraig Collard - CEOIra Duarte - EVP and CFOKevin Warner - SVP, Medical Affairs, Strategy, and EngagementMark Hensley - COOMelissa Jarel - Executive Director of LegalConference Call ParticipantsBrandon Folkes - Senior Research AnalystCarl Byrnes - Senior Research AnalystSerge Belanger - Senior AnalystOperatorGood day. Thank you for standing by. Welcome to the Heron Therapeutics Q4 2025 conference call. ...

TG Therapeutics (NasdaqCM:TGTX) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsAdam Waldman - Chief Commercialization OfficerCorinne Johnson - Vice President of Equity ResearchEmily Bodnar - Vice President of Equity ResearchJenna Bosco - VP of Corporate CommunicationsMichael Weiss - Chairman and CEOSean Power - CFOConference Call ParticipantsBrian Cheng - Vice President and Equity Research AnalystMichael Schmidt - Managing Director and Equity Research AnalystPrakhar Agrawal - Senior ...

Aurinia Pharmaceuticals (NasdaqGM:AUPH) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsGreg Keenan - Chief Medical OfficerJoe Miller - CFOPeter Greenleaf - President and CEOSahil Dhingra - Senior Equity Research AssociateWill Sawicki - AssociateConference Call ParticipantsArthur He - AnalystDavid Martin - AnalystFarzin Haque - Senior Vice President and Biotechnology Equity Research AnalystOlivia Brayer - Senior Equity AnalystOperatorGood morning. Welcome to the Aurinia Pharmaceutica ...

Novavax (NasdaqGS:NVAX) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Speaker6Welcome to Novavax Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star followed by 0. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then 1 on your touchtone phone. To withdraw your qu ...

Nautilus Biotechnology (NasdaqGS:NAUT) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Speaker2Good day, and thank you for standing by. Welcome to the Nautilus Biotechnology Q4 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To wi ...

Wave Life Sciences (NasdaqGM:WVE) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Speaker14Good morning, welcome to the Wave Life Sciences fourth quarter and full year 2025 earnings conference call. At this time, all participants are in a listen-only mode. As a reminder, this call is being recorded and webcast. I'll now turn the call over to Kate Rausch, Vice President of Corporate Affairs and Investor Relations. Please go ahead.Speaker6Thank you, Sophie. Good morning to everyone on the call. Earlier th ...